🇺🇸 Rd in United States

223 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Agranulocytosis — 59 reports (26.46%)
  2. Leukopenia — 45 reports (20.18%)
  3. Bone Marrow Failure — 20 reports (8.97%)
  4. General Physical Health Deterioration — 17 reports (7.62%)
  5. Pneumonia — 17 reports (7.62%)
  6. Acute Kidney Injury — 14 reports (6.28%)
  7. Somnolence — 14 reports (6.28%)
  8. Toxicity To Various Agents — 13 reports (5.83%)
  9. Accidental Death — 12 reports (5.38%)
  10. Cardiac Failure — 12 reports (5.38%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Rd approved in United States?

Rd does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Rd in United States?

Ascentage Pharma Group Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.